Back to Search
WAYNE TSUJI, MD
MD
Rheumatology Physician
NPI: 1306992268Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD00018284(WA)
Research & Publications (17)
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
PMID 19259765·Breast Cancer·2009
6-review
Adipogenesis induced by human adipose tissue-derived stem cells.
PMID 18759663·Tissue Eng Part A·2009
7-preclinical
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
PMID 18438853·Arthritis Rheum·2008
4-observational
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
PMID 18438830·Arthritis Rheum·2008
3-trial
Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
PMID 18278836·J Rheumatol·2008
3-trial
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
PMID 17967833·Ann Rheum Dis·2008
4-observational
Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.
PMID 17552067·J Rheumatol·2007
8-other
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
PMID 17470434·Rheumatology (Oxford)·2007
2-rct
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis.
PMID 17393390·Arthritis Rheum·2007
8-other
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
PMID 16463435·J Rheumatol·2006
2-rct
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
PMID 16142873·J Rheumatol·2005
3-trial
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
PMID 15996057·J Rheumatol·2005
3-trial
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
PMID 15843448·Ann Rheum Dis·2005
4-observational
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
PMID 15818694·Arthritis Rheum·2005
3-trial
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
PMID 15248226·Arthritis Rheum·2004
3-trial
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
PMID 14613288·Arthritis Rheum·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1959 NE PACIFIC ST
SEATTLE, WA 98195 - Phone
- (206) 598-4615
Quick Facts
- NPI
- 1306992268
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile